Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

NCT01452750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

642

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Ulcers
Duodenal Ulcers

Interventions

DRUG: TAK-438
DRUG: Placebo
DRUG: TAK-438
DRUG: Placebo
DRUG: Lansoprazole
DRUG: Placebo

Sponsor

Takeda